Log In
Print this Print this

NPD1, RX-20001

  Manage Alerts
Collapse Summary General Information
Company Resolvyx Pharmaceuticals Inc.
DescriptionSmall molecule resolvin derived from the oxidation of the omega-3 fatty acid docosahexaenoic acid (DHA)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat age-related macular degeneration (AMD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today